A novel non-toxic camptothecin formulation for cancer chemotherapy
- 31 May 2005
- journal article
- research article
- Published by Elsevier BV in Biomaterials
- Vol. 26 (14), 2115-2120
- https://doi.org/10.1016/j.biomaterials.2004.06.013
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Moving smaller in drug discovery and deliveryNature Reviews Drug Discovery, 2002
- Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutionsCarbohydrate Polymers, 2001
- Novel injectable neutral solutions of chitosan form biodegradable gels in situBiomaterials, 2000
- Clinical Pharmacokinetics of TopotecanClinical Pharmacokinetics, 1996
- Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma modelInternational Journal of Cancer, 1995
- The structural basis of camptothecin interactions with human serum albumin: impact on drug stabilityJournal of Medicinal Chemistry, 1994
- A kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some AnaloguesJournal of Pharmaceutical Sciences, 1992
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Modification of the hydroxylactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activityJournal of Medicinal Chemistry, 1989
- Growth-inhibitory effect of hexa-N-acetylchitohexaose and chitohexaose against Meth-A solid tumor.CHEMICAL & PHARMACEUTICAL BULLETIN, 1988